Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: LIVER NEOPLASMS - DRUG THERAPY , . Treffer: 34
2018
Li, M; Su, Y; Zhang, F; Chen, K; Xu, X; Xu, L; Zhou, J; Wang, W
A dual-targeting reconstituted high density lipoprotein leveraging the synergy of sorafenib and antimiRNA21 for enhanced hepatocellular carcinoma therapy.
Acta Biomater. 2018; 75(10):413-426
Doi: 10.1016/j.actbio.2018.05.049
Web of Science
PubMed
FullText
FullText_MUG
2017
Ganten, TM; Stauber, RE; Schott, E; Malfertheiner, P; Buder, R; Galle, PR; Göhler, T; Walther, M; Koschny, R; Gerken, G
Sorafenib in Patients with Hepatocellular Carcinoma-Results of the Observational INSIGHT Study.
Clin Cancer Res. 2017; 23(19):5720-5728
Doi: 10.1158/1078-0432.CCR-16-0919
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Lin, S; Hoffmann, K; Gao, C; Petrulionis, M; Herr, I; Schemmer, P
Melatonin promotes sorafenib-induced apoptosis through synergistic activation of JNK/c-jun pathway in human hepatocellular carcinoma.
J PINEAL RES. 2017; 62(3):
Doi: 10.1111/jpi.12398
Web of Science
PubMed
FullText
FullText_MUG
2015
Kaczirek, K; Ciuleanu, TE; Vrbanec, D; Marton, E; Messinger, D; Liegl-Atzwanger, B; Wrba, F; Knittelfelder, R; Lindner, E; Zielinski, CC; Streubel, B; Brodowicz, T
FOLFOX4 Plus Cetuximab for Patients With Previously Untreated Metastatic Colorectal Cancer According to Tumor RAS and BRAF Mutation Status: Updated Analysis of the CECOG/CORE 1.2.002 Study.
Clin Colorectal Cancer. 2015; 14(2):91-98
Doi: 10.1016/j.clcc.2014.12.003
Web of Science
PubMed
FullText
FullText_MUG
Stotz, M; Gerger, A; Haybaeck, J; Kiesslich, T; Bullock, MD; Pichler, M
Molecular Targeted Therapies in Hepatocellular Carcinoma: Past, Present and Future.
Anticancer Res. 2015; 35(11):5737-5744
Web of Science
PubMed
2014
Edhemovic, I; Brecelj, E; Gasljevic, G; Marolt Music, M; Gorjup, V; Mali, B; Jarm, T; Kos, B; Pavliha, D; Grcar Kuzmanov, B; Cemazar, M; Snoj, M; Miklavcic, D; Gadzijev, EM; Sersa, G
Intraoperative electrochemotherapy of colorectal liver metastases.
J Surg Oncol. 2014; 110(3): 320-327.
Doi: 10.1002/jso.23625
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Herz, C; Hertrampf, A; Zimmermann, S; Stetter, N; Wagner, M; Kleinhans, C; Erlacher, M; Schüler, J; Platz, S; Rohn, S; Mersch-Sundermann, V; Lamy, E
The isothiocyanate erucin abrogates telomerase in hepatocellular carcinoma cells in vitro and in an orthotopic xenograft tumour model of HCC.
J Cell Mol Med. 2014; 18(12): 2393-2403.
Doi: 10.1111/jcmm.12412
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Hofmann, H; von Haken, R; Werner, J; Kortes, N; Bergmann, F; Schemmer, P; Jäger, D; Radeleff, B; Schulze-Bergkamen, H
Unresectable isolated hepatic metastases from solid pseudopapillary neoplasm of the pancreas: a case report of chemosaturation with high-dose melphalan.
Pancreatology. 2014; 14(6):546-549
Doi: 10.1016/j.pan.2014.08.006
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Niederkorn, A; Wackernagel, W; Artl, M; Schwantzer, G; Aigner, B; Richtig, E
Response of patients with metastatic uveal melanoma to combined treatment with fotemustine and sorafenib.
Acta Ophthalmol. 2014; 92(8):e696-e697
Doi: 10.1111/aos.12432
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Schaap, FG; Trauner, M; Jansen, PL
Bile acid receptors as targets for drug development.
Nat Rev Gastroenterol Hepatol. 2014; 11(1):55-67
Doi: 10.1038/nrgastro.2013.151
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Thomann, S; Longerich, T; Bazhin, AV; Mier, W; Schemmer, P; Ryschich, E
Selective targeting of liver cancer with the endothelial marker CD146.
Oncotarget. 2014; 5(18):8614-8624
Doi: 10.18632/oncotarget.2345
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2013
Pavliha, D; Kos, B; Marčan, M; Zupanič, A; Serša, G; Miklavčič, D
Planning of electroporation-based treatments using Web-based treatment-planning software.
J Membr Biol. 2013; 246(11): 833-842.
Doi: 10.1007/s00232-013-9567-2
Web of Science
PubMed
FullText
FullText_MUG
Pfeiffenberger, J; Koschny, R; Hoffmann, K; Mehrabi, A; Schmitz, A; Radeleff, B; Stremmel, W; Schemmer, P; Ganten, TM
Sorafenib treatment is save and may affect survival of recurrent hepatocellular carcinoma after liver transplantation.
Langenbecks Arch Surg. 2013; 398(8):1123-1128
Doi: 10.1007/s00423-013-1114-1
Web of Science
PubMed
FullText
FullText_MUG
Yamanaka, K; Petrulionis, M; Lin, S; Gao, C; Galli, U; Richter, S; Winkler, S; Houben, P; Schultze, D; Hatano, E; Schemmer, P
Therapeutic potential and adverse events of everolimus for treatment of hepatocellular carcinoma - systematic review and meta-analysis.
Cancer Med. 2013; 2(6):862-871
Doi: 10.1002/cam4.150
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2012
Pavliha, D; Kos, B; Zupanič, A; Marčan, M; Serša, G; Miklavčič, D
Patient-specific treatment planning of electrochemotherapy: procedure design and possible pitfalls.
Bioelectrochemistry. 2012; 87(11): 265-273.
Doi: 10.1016/j.bioelechem.2012.01.007
Web of Science
PubMed
FullText
FullText_MUG
2011
Edhemovic, I; Gadzijev, EM; Brecelj, E; Miklavcic, D; Kos, B; Zupanic, A; Mali, B; Jarm, T; Pavliha, D; Marcan, M; Gasljevic, G; Gorjup, V; Music, M; Vavpotic, TP; Cemazar, M; Snoj, M; Sersa, G
Electrochemotherapy: a new technological approach in treatment of metastases in the liver.
Technol Cancer Res Treat. 2011; 10(5): 475-485.
Doi: 10.7785/tcrt.2012.500224
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Pinter, M; Sieghart, W; Hucke, F; Graziadei, I; Vogel, W; Maieron, A; Königsberg, R; Weissmann, A; Kornek, G; Matejka, J; Stauber, R; Buder, R; Grünberger, B; Schöniger-Hekele, M; Müller, C; Peck-Radosavljevic, M
Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib.
Aliment Pharmacol Ther. 2011; 34(8): 949-959.
Doi: 10.1111/j.1365-2036.2011.04823.x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2010
Hoffmann, K; Franz, C; Hinz, U; Schirmacher, P; Herfarth, C; Eichbaum, M; Büchler, MW; Schemmer, P
Liver resection for multimodal treatment of breast cancer metastases: identification of prognostic factors.
Ann Surg Oncol. 2010; 17(6):1546-1554
Doi: 10.1245/s10434-010-0931-5
Web of Science
PubMed
FullText
FullText_MUG
Hoffmann, K; Franz, C; Xiao, Z; Mohr, E; Serba, S; Büchler, MW; Schemmer, P
Sorafenib modulates the gene expression of multi-drug resistance mediating ATP-binding cassette proteins in experimental hepatocellular carcinoma.
Anticancer Res. 2010; 30(11):4503-4508
Web of Science
PubMed
2009
Kornprat, P; Schöllnast, H; Cerwenka, H; Werkgartner, G; Bernhardt, G; Mischinger, HJ
Management of colorectal liver metastases after complete response to neoadjuvant chemotherapy. A case of computertomography-guided wire marking of the liver tumor.
Int J Colorectal Dis. 2009; 24(1):125-126
Doi: 10.1007/s00384-008-0548-3
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
2008
Hauschild, A; Dummer, R; Ugurel, S; Kaehler, KC; Egberts, F; Fink, W; Both-Skalsky, J; Laetsch, B; Schadendorf, D
Combined treatment with pegylated interferon-alpha-2a and dacarbazine in patients with advanced metastatic melanoma: a phase 2 study.
Cancer. 2008; 113(6):1404-1411
Doi: 10.1002/cncr.23722
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Hoffmann, K; Glimm, H; Radeleff, B; Richter, G; Heining, C; Schenkel, I; Zahlten-Hinguranage, A; Schirrmacher, P; Schmidt, J; Büchler, MW; Jaeger, D; von Kalle, C; Schemmer, P
Prospective, randomized, double-blind, multi-center, Phase III clinical study on transarterial chemoembolization (TACE) combined with Sorafenib versus TACE plus placebo in patients with hepatocellular cancer before liver transplantation - HeiLivCa [ISRCTN24081794].
BMC Cancer. 2008; 8(3):349-349
Doi: 10.1186/1471-2407-8-349
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Jaeger, G; Bauer, F; Brezinschek, R; Beham-Schmid, C; Mannhalter, C; Neumeister, P
Hepatosplenic gammadelta T-cell lymphoma successfully treated with a combination of alemtuzumab and cladribine.
ANN ONCOL. 2008; 19(5): 1025-1026.
Doi: 10.1093/annonc/mdn119
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2007
D'Angelica, M; Kornprat, P; Gonen, M; Chung, KY; Jarnagin, WR; DeMatteo, RP; Fong, Y; Kemeny, N; Blumgart, LH; Saltz, LB
Lack of evidence for increased operative morbidity after hepatectomy with perioperative use of bevacizumab: a matched case-control study.
Ann Surg Oncol. 2007; 14(2):759-765
Doi: 10.1245/s10434-006-9074-0
Web of Science
PubMed
FullText
FullText_MUG
Herr, I; Schemmer, P; Büchler, MW
On the TRAIL to therapeutic intervention in liver disease.
Hepatology. 2007; 46(1):266-274
Doi: 10.1002/hep.21740
Web of Science
PubMed
FullText
FullText_MUG
Kornprat, P; Jarnagin, WR; Gonen, M; DeMatteo, RP; Fong, Y; Blumgart, LH; D'Angelica, M
Outcome after hepatectomy for multiple (four or more) colorectal metastases in the era of effective chemotherapy.
Ann Surg Oncol. 2007; 14(3):1151-1160
Doi: 10.1245/s10434-006-9068-y
Web of Science
PubMed
FullText
FullText_MUG
2005
Zollner, G; Wagner, M; Fickert, P; Silbert, D; Fuchsbichler, A; Zatloukal, K; Denk, H; Trauner, M
Hepatobiliary transporter expression in human hepatocellular carcinoma.
Liver Int. 2005; 25(2):367-379
Doi: 10.1111/j.1478-3231.2005.01033.x
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
2004
Lubienski, A; Bitsch, RG; Schemmer, P; Grenacher, L; Düx, M; Kauffmann, GW
Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy].
Rofo. 2004; 176(12):1794-1802
Doi: 10.1055/s-2004-813669
Web of Science
PubMed
FullText
FullText_MUG
Richtig, E; Hofmann-Wellenhof, R; Pehamberger, H; Forstinger, Ch; Wolff, K; Mischer, P; Raml, J; Fritsch, P; Zelger, B; Ratzinger, G; Koller, J; Lang, A; Konrad, K; Kindermann-Glebowski, E; Seeber, A; Steiner, A; Fialla, R; Pachinger, W; Kos, C; Klein, G; Kehrer, H; Kerl, H; Ulmer, H; Smolle, J
Temozolomide and interferon alpha 2b in metastatic melanoma stage IV.
BRIT J DERMATOL. 2004; 151(1): 91-98.
Doi: 10.1111/j.1365-2133.2004.06019.x
Web of Science
PubMed
FullText
FullText_MUG
2002
Becker, JC; Terheyden, P; Kampgen, E; Wagner, S; Neumann, C; Schadendorf, D; Steinmann, A; Wittenberg, G; Lieb, W; Brocker, EB
Treatment of disseminated ocular melanoma with sequential fotemustine, interferon alpha, and interleukin 2.
Br J Cancer. 2002; 87(8):840-845
Doi: 10.1038/sj.bjc.6600521
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Heidemann, E; Stoeger, H; Souchon, R; Hirschmann, WD; Bodenstein, H; Oberhoff, C; Fischer, JT; Schulze, M; Clemens, M; Andreesen, R; Mahlke, M; König, M; Scharl, A; Fehnle, K; Kaufmann, M
Is first-line single-agent mitoxantrone in the treatment of high-risk metastatic breast cancer patients as effective as combination chemotherapy? No difference in survival but higher quality of life were found in a multicenter randomized trial.
Ann Oncol. 2002; 13(11):1717-1729
Doi: 10.1096/annonc/mdf306
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
1995
Zoubek, A; Kajtar, P; Flucher-Wolfram, B; Holzinger, B; Mostbeck, G; Thun-Hohenstein, L; Fink, FM; Urban, C; Mutz, I; Schuler, D
Response of untreated stage IV Wilms' tumor to single dose carboplatin assessed by up front window therapy.
Med Pediatr Oncol. 1995; 25(1):8-11
Doi: 10.1002/mpo.2950250103
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
1993
Lipp, RW; Hammer, HF; Passath, A; Dobnig, H; Ramschak-Schwarzer, S; Stiegler, C; Leb, G; Krejs, GJ
Primary and follow-up studies of patients with carcinoid metastases using indium 111 octreotide--rational use of Sandostatin.
Acta Med Austriaca. 1993; 20(1-2):42-44
Web of Science
PubMed
1989
Savolaine, ER; Zeiss, J; Schlembach, PJ; Skeel, RT; McCann, K; Merrick, HW
Role of scintigraphy in establishing optimal perfusion in hepatic arterial infusion pump chemotherapy.
Am J Clin Oncol. 1989; 12(1):68-74
Doi: 10.1097/00000421-198902000-00016
Web of Science
PubMed
FullText
FullText_MUG